These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 34624198)

  • 1. Current epidemiology in hepatocellular carcinoma.
    Konyn P; Ahmed A; Kim D
    Expert Rev Gastroenterol Hepatol; 2021 Nov; 15(11):1295-1307. PubMed ID: 34624198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease Burden of Hepatocellular Carcinoma: A Global Perspective.
    Sayiner M; Golabi P; Younossi ZM
    Dig Dis Sci; 2019 Apr; 64(4):910-917. PubMed ID: 30835028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease.
    Bertot LC; Adams LA
    Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):179-187. PubMed ID: 30791782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis.
    Tang A; Hallouch O; Chernyak V; Kamaya A; Sirlin CB
    Abdom Radiol (NY); 2018 Jan; 43(1):13-25. PubMed ID: 28647765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations.
    Lodato F; Mazzella G; Festi D; Azzaroli F; Colecchia A; Roda E
    World J Gastroenterol; 2006 Dec; 12(45):7239-49. PubMed ID: 17143937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma.
    Mak LY; Cruz-Ramón V; Chinchilla-López P; Torres HA; LoConte NK; Rice JP; Foxhall LE; Sturgis EM; Merrill JK; Bailey HH; Méndez-Sánchez N; Yuen MF; Hwang JP
    Am Soc Clin Oncol Educ Book; 2018 May; 38():262-279. PubMed ID: 30231359
    [TBL] [Abstract][Full Text] [Related]  

  • 7.  Economic growth leads to increase of obesity and associated hepatocellular carcinoma in developing countries.
    Seyda Seydel G; Kucukoglu O; Altinbasv A; Demir OO; Yilmaz S; Akkiz H; Otan E; Sowa JP; Canbay A
    Ann Hepatol; 2016; 15(5):662-72. PubMed ID: 27493104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of Liver Cancer in Africa: Current and Future Trends.
    Okeke E; Davwar PM; Roberts L; Sartorius K; Spearman W; Malu A; Duguru M
    Semin Liver Dis; 2020 May; 40(2):111-123. PubMed ID: 31726474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological and etiological variations in hepatocellular carcinoma.
    Sagnelli E; Macera M; Russo A; Coppola N; Sagnelli C
    Infection; 2020 Feb; 48(1):7-17. PubMed ID: 31347138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study.
    Yu MW; Lin CL; Liu CJ; Yang SH; Tseng YL; Wu CF
    Gastroenterology; 2017 Oct; 153(4):1006-1017.e5. PubMed ID: 28711626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma: an epidemiologic view.
    El-Serag HB
    J Clin Gastroenterol; 2002; 35(5 Suppl 2):S72-8. PubMed ID: 12394209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.
    Alavi M; Law MG; Valerio H; Grebely J; Amin J; Hajarizadeh B; Selvey C; George J; Dore GJ
    J Hepatol; 2019 Aug; 71(2):281-288. PubMed ID: 31078544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma.
    Kew MC
    Pathol Biol (Paris); 2010 Aug; 58(4):273-7. PubMed ID: 20378277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma and non-alcoholic fatty liver disease.
    Golabi P; Rhea L; Henry L; Younossi ZM
    Hepatol Int; 2019 Nov; 13(6):688-694. PubMed ID: 31701393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of hepatocellular carcinoma: consider the population.
    Mittal S; El-Serag HB
    J Clin Gastroenterol; 2013 Jul; 47 Suppl(0):S2-6. PubMed ID: 23632345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma. A worldwide problem and the major risk factors.
    Simonetti RG; Cammà C; Fiorello F; Politi F; D'Amico G; Pagliaro L
    Dig Dis Sci; 1991 Jul; 36(7):962-72. PubMed ID: 1649041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
    Streba LA; Vere CC; Rogoveanu I; Streba CT
    World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity.
    Seeff LB; Hoofnagle JH
    Oncogene; 2006 Jun; 25(27):3771-7. PubMed ID: 16799618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and natural history of hepatocellular carcinoma.
    McGlynn KA; London WT
    Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):3-23. PubMed ID: 15757802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Epidemiology of Hepatocellular Carcinoma in the USA.
    Kim HS; El-Serag HB
    Curr Gastroenterol Rep; 2019 Apr; 21(4):17. PubMed ID: 30976932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.